Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

35.10
-0.0700-0.20%
Volume:1K
Turnover:50.03K
Market Cap:1.93M
PE:- -
High:35.10
Open:35.10
Low:35.10
Close:35.17
52wk High:36.54
52wk Low:23.88
Shares:55.00K
Float Shares:55.00K
Volume Ratio:0.79
T/O Rate:2.59%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.

TIPRANKS
·
Aug 27

What Thermo Fisher Scientific (TMO)'s New Orbitrap Isora Platform Means For Shareholders

Simply Wall St.
·
Aug 27

Thermo Fisher CEO Marc N. Casper Sells 275 Common Shares Worth $172,529.69

Reuters
·
Aug 27

Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat

Reuters
·
Aug 27

Roche receives FDA approval for companion diagnostic tests for Ziihera

TIPRANKS
·
Aug 27

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

TIPRANKS
·
Aug 27

Revolution Medicines announces FDA approval of Rasonque in adults

TIPRANKS
·
Aug 27

Unified Pathology Index Launches Nationwide, One Code Bridges Data Gaps for Precision Care

Stock News
·
Aug 26

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

TIPRANKS
·
Aug 25

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.
·
Aug 25

Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares

Reuters
·
Aug 25

Illumina management to meet virtually with Piper Sandler

TIPRANKS
·
Aug 25

Thermo Fisher CEO Marc N. Casper Disposes of $15.43 Million in Common Shares

Reuters
·
Aug 25

Guardant Health to Appeal Delaware Court Ruling in Patent Dispute; Shares Fall

MT Newswires Live
·
Aug 25

Guardant Health to appeal federal district court judgment in TwinStrand case

TIPRANKS
·
Aug 25

Guardant Health, Inc.: Remains Confident That it Did not Infringe Asserted Patents

THOMSON REUTERS
·
Aug 25

Guardant Health, - Current Guardant Reveal and Shield Products Excluded from Final Court Order

THOMSON REUTERS
·
Aug 25

Guardant Health to Appeal Federal District Court Judgment

THOMSON REUTERS
·
Aug 25

U.S. Court Orders Guardant to Pay $245 Million in DNA Sequencing Patent Dispute

Reuters
·
Aug 25

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

TIPRANKS
·
Aug 24